For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Products
Life, Liberty, And Cell Phones
From the August 2001 Edition of CEI Update A car speeds down a busy highway, zigzagging unpredictably from lane to…
Op-Eds
Cutting Regulation From the EPA: Gene-splicing Policy Should Be Excised
Miller Op-Ed in The Washington TImes Miller Op-Ed in The Washington Times A persistent criticism of the…
Op-Eds
Plants Are Not Pesticides
Miller Op-Ed in The National Post<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> A New U.S. EPA…
Study
The Leaked Study on CAFE: Why It Doesn’t Justify Higher Fuel Economy Standards
This past Monday, the New York Times carried a front-page story on the National Academy of Sciences’ auto fuel-economy study.[1] The…
Op-Eds
Massachusetts: Go Slow on Disconnecting Drivers
Gattuso and Rupert Op-Ed in The Lowell Sun<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> …
News Release
CEI Criticizes FDA Delay In Approving New Heart Valve
Washington, DC, July 27, 2001—The Food and Drug Administration acted far too slowly in approving the Omnicarbon heart valve, the Competitive Enterprise Institute…
